Quest Diagnostics Incorporated (BIT:1QDX)
Italy
· Delayed Price · Currency is EUR 148.45
0.00 (0.00%)
At close: Mar 3, 2026
Quest Diagnostics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 11,035 | 9,872 | 9,252 | 9,883 | 10,788 | Upgrade
|
| Revenue Growth (YoY) | 11.78% | 6.70% | -6.39% | -8.39% | 14.32% | Upgrade
|
| Cost of Revenue | 7,357 | 6,599 | 6,186 | 6,431 | 6,571 | Upgrade
|
| Gross Profit | 3,678 | 3,273 | 3,066 | 3,452 | 4,217 | Upgrade
|
| Selling, General & Admin | 1,920 | 1,731 | 1,630 | 1,838 | 1,723 | Upgrade
|
| Amortization of Goodwill & Intangibles | 154 | 127 | 108 | 120 | 103 | Upgrade
|
| Other Operating Expenses | -1 | 1 | 12 | -3 | -2 | Upgrade
|
| Operating Expenses | 2,073 | 1,859 | 1,750 | 1,955 | 1,824 | Upgrade
|
| Operating Income | 1,605 | 1,414 | 1,316 | 1,497 | 2,393 | Upgrade
|
| Interest Expense | -277 | -226 | -163 | -148 | -152 | Upgrade
|
| Interest & Investment Income | 13 | 25 | 11 | 10 | 1 | Upgrade
|
| Earnings From Equity Investments | 42 | 19 | 26 | 44 | 78 | Upgrade
|
| Other Non Operating Income (Expenses) | 26 | 18 | 20 | -55 | 55 | Upgrade
|
| EBT Excluding Unusual Items | 1,409 | 1,250 | 1,210 | 1,348 | 2,375 | Upgrade
|
| Merger & Restructuring Charges | -83 | -50 | -54 | -69 | -12 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | 314 | Upgrade
|
| Legal Settlements | -22 | - | - | - | - | Upgrade
|
| Other Unusual Items | 56 | -6 | - | - | - | Upgrade
|
| Pretax Income | 1,360 | 1,194 | 1,156 | 1,279 | 2,677 | Upgrade
|
| Income Tax Expense | 314 | 273 | 248 | 264 | 597 | Upgrade
|
| Earnings From Continuing Operations | 1,046 | 921 | 908 | 1,015 | 2,080 | Upgrade
|
| Net Income to Company | 1,046 | 921 | 908 | 1,015 | 2,080 | Upgrade
|
| Minority Interest in Earnings | -54 | -50 | -54 | -69 | -85 | Upgrade
|
| Net Income | 992 | 871 | 854 | 946 | 1,995 | Upgrade
|
| Preferred Dividends & Other Adjustments | 4 | 5 | 4 | 4 | 7 | Upgrade
|
| Net Income to Common | 988 | 866 | 850 | 942 | 1,988 | Upgrade
|
| Net Income Growth | 13.89% | 1.99% | -9.72% | -52.58% | 39.41% | Upgrade
|
| Shares Outstanding (Basic) | 111 | 111 | 112 | 116 | 125 | Upgrade
|
| Shares Outstanding (Diluted) | 113 | 113 | 113 | 118 | 128 | Upgrade
|
| Shares Change (YoY) | - | - | -4.24% | -7.81% | -5.88% | Upgrade
|
| EPS (Basic) | 8.90 | 7.80 | 7.59 | 8.12 | 15.90 | Upgrade
|
| EPS (Diluted) | 8.75 | 7.69 | 7.49 | 7.97 | 15.55 | Upgrade
|
| EPS Growth | 13.78% | 2.67% | -6.02% | -48.75% | 48.52% | Upgrade
|
| Free Cash Flow | 1,359 | 909 | 864 | 1,314 | 1,830 | Upgrade
|
| Free Cash Flow Per Share | 12.03 | 8.04 | 7.65 | 11.14 | 14.30 | Upgrade
|
| Dividend Per Share | 3.200 | 3.000 | 2.840 | 2.640 | 2.480 | Upgrade
|
| Dividend Growth | 6.67% | 5.63% | 7.58% | 6.45% | 10.71% | Upgrade
|
| Gross Margin | 33.33% | 33.15% | 33.14% | 34.93% | 39.09% | Upgrade
|
| Operating Margin | 14.54% | 14.32% | 14.22% | 15.15% | 22.18% | Upgrade
|
| Profit Margin | 8.95% | 8.77% | 9.19% | 9.53% | 18.43% | Upgrade
|
| Free Cash Flow Margin | 12.31% | 9.21% | 9.34% | 13.30% | 16.96% | Upgrade
|
| EBITDA | 2,175 | 1,907 | 1,755 | 1,934 | 2,801 | Upgrade
|
| EBITDA Margin | 19.71% | 19.32% | 18.97% | 19.57% | 25.96% | Upgrade
|
| D&A For EBITDA | 570 | 493 | 439 | 437 | 408 | Upgrade
|
| EBIT | 1,605 | 1,414 | 1,316 | 1,497 | 2,393 | Upgrade
|
| EBIT Margin | 14.54% | 14.32% | 14.22% | 15.15% | 22.18% | Upgrade
|
| Effective Tax Rate | 23.09% | 22.86% | 21.45% | 20.64% | 22.30% | Upgrade
|
| Advertising Expenses | 35 | 28 | 31 | 74 | 78 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.